Evidence map›Paper›PMID 32277807›Full record

ArticleBJS open2020

Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.

K Tai, S Komatsu, K Sofue, M Kido, M Tanaka, K Kuramitsu, M Awazu, H Gon, D Tsugawa, H Yanagimoto and 4 more

Open access · goldAbstract read
In one paragraph

Article in BJS open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

K TaiDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.ORCID 0000-0003-2372-4100
S KomatsuDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.ORCID 0000-0001-9059-2473
K SofueDepartment of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
M KidoDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
M TanakaDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
K KuramitsuDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
M AwazuDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
H GonDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
D TsugawaDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.ORCID 0000-0001-7526-9563
H YanagimotoDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
H ToyamaDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
S MurakamiClinical and Translational Research Centre, Kobe University Hospital, Kobe, Hyogo, Japan.
T MurakamiDepartment of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
T FukumotoDepartment of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Hyogo, Japan.
Kobe University · JPKobe University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough total tumour volume (TTV) may have prognostic value for hepatic resection in certain solid cancers, its importance in colorectal liver metastases (CRLM) remains unexplored. This study investigated its prognostic value in patients with resectable CRLM.

methodThis was a retrospective review of patients who underwent hepatic resection for CRLM between 2008 and 2017 in a single institution. TTV was measured from CT images using three-dimensional construction software; cut-off values were determined using receiver operating characteristic (ROC) curve analyses. Potential prognostic factors, overall survival (OS) and recurrence-free survival (RFS) were determined using multivariable and Kaplan-Meier analyses.

resultsSome 94 patients were included. TTV cut-off values for OS and RFS were 100 and 10 ml respectively. Right colonic primary tumours, primary lymph node metastasis and bilobar liver metastasis were included in the multivariable analysis of OS; a TTV of 100 ml or above was independently associated with poorer OS (hazard ratio (HR) 6·34, 95 per cent c.i. 2·08 to 17·90; P = 0·002). Right colonic primary tumours and primary lymph node metastasis were included in the RFS analysis; a TTV of 10 ml or more independently predicted poorer RFS (HR 1·90, 1·12 to 3·57; P = 0·017). The 5-year OS rate for a TTV of 100 ml or more was 41 per cent, compared with 67 per cent for a TTV below 100 ml (P = 0·006). Corresponding RFS rates with TTV of 10 ml or more, or less than 10 ml, were 14 and 58 per cent respectively (P = 0·009). A TTV of at least 100 ml conferred a higher rate of unresectable initial recurrences (12 of 15, 80 per cent) after initial hepatic resection.

conclusionTTV was associated with RFS and OS after initial hepatic resection for CRLM; TTV of 100 ml or above was associated with a higher rate of unresectable recurrence.

Indexed as

Tumor BurdenAgedColorectal NeoplasmsFemaleHumansJapanLiver NeoplasmsLymphatic MetastasisMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRetrospective StudiesSurvival AnalysisTime Factors

Identifiers

PMID32277807
PMCPMC7260417
OpenAlexW3015272797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.